{"id":11347,"date":"2026-02-05T20:52:00","date_gmt":"2026-02-05T20:52:00","guid":{"rendered":"https:\/\/actualitelibre.com\/progesterone-market-expected-to-reach-3-17-billion-by-the-2031-supported-by-expanding-use-in-womens-health\/"},"modified":"2026-02-06T02:50:14","modified_gmt":"2026-02-06T02:50:14","slug":"progesterone-market-expected-to-reach-3-17-billion-by-the-2031-supported-by-expanding-use-in-womens-health","status":"publish","type":"post","link":"https:\/\/actualitelibre.com\/en\/progesterone-market-expected-to-reach-3-17-billion-by-the-2031-supported-by-expanding-use-in-womens-health\/","title":{"rendered":"Progesterone Market Expected to Reach 3.17 billion by the 2031, Supported by Expanding Use in Women\u2019s Health"},"content":{"rendered":"


\n<\/p>\n

\n

Mordor Intelligence has published a new report on\u00a0<\/span><\/b>Progesterone<\/span><\/b>\u00a0Market, offering a comprehensive analysis of trends, growth drivers, and future projections.<\/span><\/b>\u00a0<\/span><\/p>\n

\u00a0<\/span><\/p>\n

Introduction: Progesterone Market Overview<\/span><\/b>\u00a0<\/span><\/p>\n

The\u00a0<\/span>progesterone market\u00a0size<\/span><\/a>\u00a0is estimated at USD 2.07 billion in 2026, and is expected to reach USD 3.17 billion by 2031, at a CAGR of 8.92% during the forecast period (2026-2031),\u00a0driven\u00a0by its wide application in women\u2019s health and reproductive medicine. According to Mordor Intelligence, the progesterone market size in the introduction phase of the forecast reflects steady demand from fertility treatment centers, hospitals, and gynecology practices. Progesterone is routinely used in\u00a0assisted\u00a0reproductive procedures, hormone replacement therapy, and the management of menstrual and pregnancy-related conditions.<\/span>\u00a0<\/span><\/p>\n

Growth in the progesterone market is supported by rising awareness of reproductive health, increasing use of assisted reproductive techniques, and broader access to hormone-based therapies. The progesterone market share is distributed across oral, injectable, and vaginal formulations, allowing physicians to tailor treatment based on patient needs and clinical protocols. This diversity of use cases continues to support consistent progesterone market growth across regions.<\/span>\u00a0<\/span><\/p>\n

Key Trends Shaping the Progesterone Market<\/span><\/b>\u00a0<\/span><\/p>\n

Rising Use in Assisted Reproductive Procedures<\/span><\/b>
\nOne of the most significant progesterone market trends is the increasing reliance on progesterone supplementation during assisted reproductive treatments. Fertility clinics routinely use progesterone to support luteal phase and early pregnancy, which continues to drive demand within specialized care settings.<\/span>\u00a0<\/span><\/p>\n

Continued Demand in Hormone Replacement Therapy<\/span><\/b>
\nProgesterone\u00a0remains\u00a0a key\u00a0component\u00a0of hormone replacement therapy regimens, particularly for women undergoing menopause management. Its role in balancing estrogen therapy supports steady prescription volumes and contributes to stable progesterone market analysis outcomes.<\/span>\u00a0<\/span><\/p>\n

Preference for Multiple Dosage Forms<\/span><\/b>
\nHealthcare providers\u00a0benefit\u00a0from the availability of progesterone in oral, injectable, and vaginal formulations. This flexibility supports patient adherence and allows individualized treatment approaches, strengthening progesterone market share across outpatient and hospital channels.<\/span>\u00a0<\/span><\/p>\n

Growth in Gynecological and Obstetric Applications<\/span><\/b>
\nProgesterone is widely used in managing menstrual disorders, supporting pregnancy, and reducing certain pregnancy-related risks. These applications continue to reinforce routine demand and support long-term progesterone market growth.<\/span>\u00a0<\/span><\/p>\n

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:\u00a0<\/span><\/b>https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/progesterone-market?utm_source=emailwire<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

Progesterone Market Segmentation<\/span><\/b>\u00a0<\/span><\/p>\n

The progesterone market is segmented by formulation, application, and distribution channel, reflecting its broad clinical usage.<\/span>\u00a0<\/span><\/p>\n

By Product Type<\/span><\/b>
\nNatural progesterone<\/span>
\nPlant-sterol-derived<\/span>
\nAnimal-source-derived<\/span>
\nSynthetic progesterone<\/span>
\nSteroidal (17-\u03b1-hydroxyprogesterone caproate, etc.)<\/span>
\nNon-steroidal (norethindrone, etc.)<\/span>\u00a0<\/span><\/p>\n

By Mode of Delivery<\/span><\/b>
\nInjectable<\/span>
\nSuspended form<\/span>
\nOral<\/span>
\nOther modes of delivery<\/span>\u00a0<\/span><\/p>\n

By Application<\/span><\/b>
\nMenopause<\/span>
\nDysfunctional uterine bleeding<\/span>
\nEndometrial cancer<\/span>
\nContraception<\/span>
\nHyperplastic precursor lesions<\/span>
\nOther\u00a0applications<\/span>\u00a0<\/span><\/p>\n

By End User<\/span><\/b>
\nHospitals and clinics<\/span>
\nFertility centers<\/span>
\nAmbulatory surgical centers<\/span>
\nRetail and online pharmacies<\/span>
\nResearch and academic institutes<\/span>\u00a0<\/span><\/p>\n

By Distribution Channel<\/span><\/b>
\nPrescription (Rx)<\/span>
\nOver-the-counter\u00a0(OTC)<\/span>
\nCompounding pharmacies<\/span>\u00a0<\/span><\/p>\n

Each segment contributes differently to progesterone market size depending on treatment setting and patient population.<\/span>\u00a0<\/span><\/p>\n

Progesterone Market\u00a0Competitive Landscape\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n

The progesterone market includes both multinational pharmaceutical companies and regional manufacturers supplying branded and generic products. Key players focus on\u00a0maintaining\u00a0consistent product quality, regulatory compliance, and broad distribution networks.<\/span>\u00a0<\/span><\/p>\n

Major Companies include:<\/span><\/b>\u00a0<\/span><\/p>\n